LLS (Leukemia & Lymphoma Society)
The Leukemia & Lymphoma Society (LLS), headquartered in the United States, is a leading non-profit organisation dedicated to funding research and providing support for patients affected by blood cancers, including leukemia, lymphoma, and myeloma. Founded in 1949, LLS has made significant strides in advancing treatments and improving patient outcomes, with notable milestones such as the development of targeted therapies and immunotherapies. Operating across major regions in the US, LLS offers a range of core services, including patient education, financial assistance, and advocacy for blood cancer research funding. What sets LLS apart is its commitment to investing in innovative research and its comprehensive support network for patients and families. With a strong market position, LLS has raised billions for research and has played a pivotal role in increasing survival rates for blood cancer patients, making it a vital resource in the fight against these diseases.
DitchCarbon Score
How does LLS (Leukemia & Lymphoma Society)'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Membership Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
LLS (Leukemia & Lymphoma Society)'s score of 23 is lower than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
LLS (Leukemia & Lymphoma Society)'s reported carbon emissions
The Leukemia & Lymphoma Society (LLS), headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with their operations. As LLS does not inherit emissions data from a parent organisation, all information regarding their climate commitments remains unspecified. Without concrete emissions data or reduction initiatives, it is challenging to assess their environmental impact or commitments to sustainability. In the broader context, many organisations are increasingly adopting science-based targets and sustainability initiatives to mitigate climate change, but LLS has yet to publicly outline such commitments.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
LLS (Leukemia & Lymphoma Society) is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
